ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $993,000 | +566.4% | 174,298 | +1046.0% | 0.00% | – |
| Q4 2021 | $149,000 | -89.1% | 15,209 | +18.0% | 0.00% | -100.0% |
| Q3 2021 | $1,365,000 | +65.7% | 12,894 | +33.5% | 0.00% | – |
| Q2 2021 | $824,000 | -25.9% | 9,657 | -0.4% | 0.00% | -100.0% |
| Q1 2021 | $1,112,000 | -58.6% | 9,692 | -49.5% | 0.00% | -50.0% |
| Q4 2020 | $2,689,000 | +433.5% | 19,208 | +210.6% | 0.00% | – |
| Q3 2020 | $504,000 | +12.2% | 6,184 | -1.1% | 0.00% | – |
| Q2 2020 | $449,000 | -76.6% | 6,255 | -68.9% | 0.00% | -100.0% |
| Q4 2019 | $1,916,000 | +20.2% | 20,097 | -0.9% | 0.00% | 0.0% |
| Q3 2019 | $1,594,000 | – | 20,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |